Biophoton Therapy Restores Hemorheology in Chronic Stroke: Live Blood Evidence of Microvascular Recovery

Authors

  • Ya Hu First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE, 19720, USA Author
  • Leon Chien First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE, 19720, USA Author
  • Helen Y Gu First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE, 19720, USA Author
  • James Z Liu First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE, 19720, USA Author

DOI:

https://doi.org/10.47363/JNRRR/2025(7)229

Keywords:

Biophoton Therapy, Chronic Stroke, Live Blood Analysis, Blood Rheology, Microcirculation, Mitochondrial Function

Abstract

Background: Chronic stroke is associated with long-term impairments in microvascular circulation, blood rheology, and cellular metabolism, which collectively limit recovery. Biophoton generators emit ultraweak, coherent photons that may restore mitochondrial function, enhance red blood cell morphology, and improve systemic perfusion.

Methods: A 70-year-old male with chronic ischemic stroke underwent 24 days of continuous exposure to Tesla BioHealer® devices. Capillary blood samples were collected on Days 0, 2, 14, 17, and 24 and analyzed using darkfield live blood microscopy. Five hematologic parameters RBC aggregation, fibrin thread density, membrane integrity, plasma debris, and immune or platelet activity were semi-quantitatively scored (0–4), yielding a raw severity score (0–20) and a composite blood health score (0–10).

Results: At baseline, the patient exhibited severe rouleaux formation, dense fibrin networks, and distorted erythrocyte morphology (composite score = 2.0). By Day 24, >80% of RBCs were freely separated with clear plasma and no detectable fibrin, yielding a composite score of 9.5 and a >90% reduction in the raw severity score. These findings suggest significantly improved blood fluidity, oxygen delivery capacity, and microvascular integrity.

Conclusions: Biophoton therapy produced rapid, sustained improvements in blood morphology and rheology in a chronic stroke patient. These hematologic changes may reflect systemic recovery mechanisms observed in larger clinical studies, including improved cerebral perfusion and neurofunctional restoration. Controlled trials are warranted to further evaluate biophoton therapy as a noninvasive adjunct for stroke rehabilitation.

Author Biographies

  • Ya Hu, First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE, 19720, USA

    First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE, 19720, USA

  • Leon Chien, First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE, 19720, USA

    First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE, 19720, USA

  • Helen Y Gu, First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE, 19720, USA

    First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE, 19720, USA

  • James Z Liu, First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE, 19720, USA

    First Institute of All Medicines, 1000 Uniqema Blvd, New Castle, DE, 19720, USA

Downloads

Published

2025-08-05

Issue

Vol. 7 No. 8 (2025): Volume 7 Issue 8

Section

Articles